Qdenga

TAK-003 · Takeda

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Qdenga, covering 2025-03-27 to 2026-08-19. Get the full timeline:

Most recent: EMA Authorised: Qdenga (Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated;Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated;Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated;Dengue virus, serotype 2, live, attenuated) — Takeda Pharmaceuticals International AG Ireland Branch

See pricing